The director of the NCI on cancer research and clinical trials during the COVID-19 pandemic
Cancer hasn\u2019t stopped during this pandemic and neither has the National Cancer Institute or American Cancer Society.\n\nNed Sharpless, MD, director of the National Cancer Institute, joined the TheoryLab podcast to talk about how we can sustain research momentum during the pandemic, what new research opportunities have arisen, and how clinical trials have been impacted. \n\n2:57 \u2013 How his job has changed as a result of the coronavirus, and new tasks taken on by the NCI\n\n5:09 \u2013 How we can sustain research momentum in the fight against cancer during this pandemic\n\n8:57 \u2013 On why data sharing among scientists, always an NCI priority, has become even more important\n\n11:02 \u2013 Several interesting cancer research opportunities that have arisen as a result of COVID-19\n\n14:23 \u2013 How the pandemic has impacted clinical trials for cancer patients\n\n19:48 \u2013 A message he\u2019d like to share with cancer patients and their loved ones